{
  "id": 20572229,
  "title": "Neuropace CEO Joel Becker buys $99,293 in company stock",
  "url": "https://urgent.news/2026/11/18/neuropace-ceo-joel-becker-buys-99-293-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-18T09:01:15.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/neuropace-ceo-joel-becker-buys-99293-in-company-stock-93CH-5035179"
  },
  "original_language": "en",
  "account": null,
  "summary": "NeuroPace CEO Joel Becker recently purchased 11,891 shares of the company's common stock, totaling $99,293, on November 17, 2026, with prices ranging from $7.92 to $8.50 per share. This insider buying comes amid a 34.5% decline in the stock price over the past week, as it trades at $8.20. Despite the stock being in oversold territory according to InvestingPro analysis and its Fair Value calculation suggesting potential overvaluation, Becker's purchase brings his direct beneficial ownership to 149,891 shares. The transactions were made in compliance with SEC regulations and broker-dealer pre-clearance procedures. Meanwhile, NeuroPace reported a revenue shortfall in the third quarter, with revenue at $23.1 million, below the expected $27 million, and a 1.1% decline from the previous year. The company adjusted its full-year revenue outlook to a range of $91 million to $92 million, down from the previous estimate of $99.5 million to $101.5 million. This has led to price reductions from analysts at Mizuho and KeyBanc, though both maintain an Outperform rating.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}